Foghorn Therapeutics FHTX
NASDAQ FHTX
$2.03 +0.02 (+0.75%)
As of: Oct 21, 2026 · 12:47 PM EDT

Foghorn Therapeutics (FHTX) Current Leases (2021)

Updated

Foghorn Therapeutics (FHTX) reported Current Leases of $106,000 for Q2 2021, up 1.0% from the prior quarter.

Analysis

Foghorn Therapeutics (FHTX) Current Leases (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,132.21 Bn 1,100.80 Bn 19.71 Bn -
2 Johnson & Johnson 616.27 Bn 534.80 Bn 17.26 Bn -
3 AbbVie 500.10 Bn 473.21 Bn 12.70 Bn -
4 Merck 366.86 Bn 321.23 Bn 12.21 Bn -
5 Novartis Ag 297.92 Bn 261.91 Bn 11.24 Bn -
6 Astrazeneca 261.53 Bn 235.22 Bn 12.86 Bn -
7 Amgen 234.99 Bn 190.39 Bn 7.24 Bn -
8 Gilead Sciences 190.14 Bn 164.34 Bn 6.22 Bn -
9 Pfizer 169.63 Bn 116.28 Bn 10.94 Bn -
10 Foghorn Therapeutics 143.02 Mn -182.93 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 106,000.00
Mar 31, 2021 105,000.00
API Access

Foghorn Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=FHTX&period=max&api_key=YOUR_API_KEY